Dublin, April 14, 2026 (GLOBE NEWSWIRE) -- The "Drafting Commercial Contracts for the Pharmaceutical Industry (May 20th - May 21st, 2026)" training has been added to ResearchAndMarkets.com's offering.
This unique and highly interactive two-day training course looks at all stages of the contracting process and aims to deliver applied training through a balanced blend of practical learning. The presenters will use a mixture of practical exercises and cases from the pharmaceutical industry to ensure you leave the course with the knowledge and skills to perfect all stages of the contracting process.
In such a highly regulated industry and in these turbulent and uncertain times, understanding the key challenges of negotiating and drafting an effective and watertight contract on an international level are complex topics. They can be difficult for even the most well-equipped in-house lawyer and most often it is not the lawyer in the driving seat.
Commercial managers from all areas of the pharmaceutical industry are leading negotiations and drafting and managing key contracts on a daily basis. It is vital that both legal counsel and commercial executives not only have the key skills and tactics to create a win:win scenario but also the knowledge to ensure any agreement is within current laws and regulations. The alternative is the exposure of the organisation to unnecessary risk and costly disputes.
This training programme will:
- Deliver an in-depth examination of intellectual property issues that affect pharmaceutical industry agreements
- Focus on competition regulations pertinent to pharmaceutical industry agreements
- Analyse the commercial and legal issues affecting pharmaceutical industry agreements
- Examine collaboration and licensing agreements
Benefits of attending
- Update your practical skills when drafting effective licensing and collaboration agreements
- Explore the current issues relating to IP including the Unitary Patent and Unified Patent Court
- Understand the key intellectual property issues affecting pharmaceutical industry agreements
- Explore the implications of SPCs for pharmaceutical industry agreements
- Learn how to draft contracts to avoid anti-trust infringement
- Familiarise yourself with the key commercial and legal issues that affect pharmaceutical industry agreements
- Gain knowledge of the key issues in clinical trial agreements, contract manufacturing agreements and co-promotion, co-marketing and distribution agreements, and material transfer agreements
- Get to grips with competition law relevant to doing deals in the pharmaceutical industry and best practice tactics to use
Who Should Attend:
Personnel from R&D, clinical, regulatory, commercial, sales and marketing, manufacturing, distribution and purchasing functions, including:
- In-house counsel
- Commercial and contract managers
- Business development managers
- Purchasing and procurement personnel
- Heads of legal departments
- Legal advisers
- Patent, IP, trade marks or licensing counsel
Key Topics Covered:
Day 1
- Understanding licensing and collaboration agreements
- Workshop: Understanding licensing and collaboration agreements
- The Unitary Patent and the UPC One Year On
- Third-party IP rights - freedom-to-operate searches and implications for pharmaceutical industry agreements
- Supplementary protection certificates (SPCs) - securing the full commercial potential of your product
- Understanding and drafting R&D agreements
Day 2
- Medicines regulations using regulatory processes to define contractual obligations
- Key issues in clinical trials and related agreements
- Key issues in contract manufacturing agreements
- Key issues in co-promotion, co-marketing and distribution agreements
- Key issues in material transfer agreements
- Introduction to relevant EU competition law rules
- Practical workshop: Current competition law issues
CPD Hours: 12
For more information about this training visit https://www.researchandmarkets.com/r/yuxu64
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
